Two Sigma Securities, LLC Myriad Genetics Inc Call Options Transaction History

Two Sigma Securities, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $397,558 - $665,176	-14,600 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $255,476 - $342,312	-6,800 Reduced 31.78%	14,600 $672,000
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $141,525 - $204,867	5,100 Added 31.29%	21,400 $800,000
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $469,929 - $668,463	16,300 New	16,300 $482,000

249

90.6M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.04B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.